buserelin has been researched along with Obesity in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chlouverakis, CS; Piaditis, GP; Rangou, DB; Spina, J; Stamataki, KE | 1 |
Fridström, M; Hillensjö, T; Pousette, A; Sjöblom, P | 1 |
Ben-Shlomo, A; Hagag, P; Herzianu, I; Weiss, M | 1 |
Abyholm, T; Dale, PO; Fedorcsák, P; Storeng, R; Tanbo, T | 1 |
Ouerghi, D; Richard, D; Rivest, S | 1 |
Andreani, CL; Apa, R; Caruso, A; Fortini, A; Fulghesu, AM; Lanzone, A; Mancuso, S | 1 |
Andreani, CL; Caruso, A; Fulghesu, AM; Lanzone, A; Le Donne, M; Mancuso, S; Muscatello, R; Pappalardo, S; Proto, C | 1 |
1 trial(s) available for buserelin and Obesity
Article | Year |
---|---|
Diagnosis of polycystic ovary disease in obese women with a 24-hour hormone profile after buserelin stimulation.
Topics: Adolescent; Adult; Buserelin; Female; Fertility Agents, Female; Gonadal Steroid Hormones; Humans; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Sensitivity and Specificity | 2000 |
6 other study(ies) available for buserelin and Obesity
Article | Year |
---|---|
Ovarian function in women with non-insulin dependent diabetes mellitus.
Topics: Adult; Androstenedione; Buserelin; Diabetes Mellitus, Type 2; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Obesity; Ovary; Testosterone | 1996 |
Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Infertility, Female; Obesity; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Retrospective Studies | 1997 |
The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome.
Topics: Androstenedione; Buserelin; Drug Resistance; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Recombinant Proteins; Sex Hormone-Binding Globulin; Sperm Injections, Intracytoplasmic; Testosterone; Treatment Outcome | 2001 |
Adrenalectomy attenuates the effect of chemical castration on energy balance in rats.
Topics: Adipose Tissue; Adrenalectomy; Analysis of Variance; Animals; Body Composition; Buserelin; Eating; Energy Metabolism; Female; Multivariate Analysis; Obesity; Ovariectomy; Rats; Rats, Inbred Strains; Weight Gain | 1992 |
Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
Topics: Adult; Buserelin; Fasting; Female; Glucose Tolerance Test; Gonadal Steroid Hormones; Humans; Insulin; Insulin Secretion; Obesity; Ovary; Pituitary Hormone-Releasing Hormones; Polycystic Ovary Syndrome | 1990 |
Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.
Topics: Adult; Androstenedione; Buserelin; Estradiol; Female; Glucose; Growth Hormone; Humans; Hyperinsulinism; Obesity; Polycystic Ovary Syndrome; Somatomedins; Testosterone | 1990 |